Cell Biotech Co. Ltd Market Cap ($77.90 Million)
Market Cap & Net Worth: Cell Biotech Co. Ltd (049960)
Cell Biotech Co. Ltd market cap. Cell Biotech Co. Ltd (KQ:049960) has a market capitalization of $77.90 Million (₩114.95 Billion) as of November 6, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #20003 globally and #1056 in its home market, demonstrating a -0.13% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cell Biotech Co. Ltd's stock price ₩14890.00 by its total outstanding shares 7720000 (7.72 Million). Also see Cell Biotech Co. Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.
Cell Biotech Co. Ltd Market Cap History (2015–2026)
Cell Biotech Co. Ltd market cap history from 2015 to 2026. Data shows change from $244.96 Million to $77.90 Million (-10.53% CAGR). Check Cell Biotech Co. Ltd stock quote for real-time trading data and today's change.
Index Memberships
Cell Biotech Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$207.23 Billion | 0.04% | #446 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$207.23 Billion | 0.04% | #446 of 1384 |
Weight: Cell Biotech Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Cell Biotech Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cell Biotech Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Cell Biotech Co. Ltd annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Cell Biotech Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Cell Biotech Co. Ltd's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $244.96 Million | $49.50 Billion | $17.51 Billion | 0.00x | 0.01x |
| 2016 | $211.10 Million | $58.28 Billion | $18.50 Billion | 0.00x | 0.01x |
| 2017 | $176.02 Million | $61.06 Billion | $18.20 Billion | 0.00x | 0.01x |
| 2018 | $126.00 Million | $62.54 Billion | $19.38 Billion | 0.00x | 0.01x |
| 2019 | $87.90 Million | $45.96 Billion | $7.23 Billion | 0.00x | 0.01x |
| 2020 | $111.25 Million | $45.58 Billion | $3.19 Billion | 0.00x | 0.03x |
| 2021 | $91.44 Million | $46.87 Billion | $10.38 Billion | 0.00x | 0.01x |
| 2022 | $63.79 Million | $50.53 Billion | $8.28 Billion | 0.00x | 0.01x |
| 2023 | $58.70 Million | $53.79 Billion | $6.30 Billion | 0.00x | 0.01x |
| 2024 | $74.66 Million | $49.91 Billion | $15.13 Billion | 0.00x | 0.00x |
Competitor Companies of 049960 by Market Capitalization
Companies near Cell Biotech Co. Ltd in the global market cap rankings as of November 6, 2026. Also see 049960 asset base for a full breakdown of the balance sheet.
Key companies related to Cell Biotech Co. Ltd by market ranking:
- Peptron Inc (KQ:087010): Ranked #8741 globally with a market cap of $973.22 Million USD ( ₩1.44 Trillion KRW).
- Bioneer Corporation (KQ:064550): Ranked #19020 globally with a market cap of $100.18 Million USD ( ₩147.83 Billion KRW).
- Macrogen Inc (KQ:038290): Ranked #20165 globally with a market cap of $74.50 Million USD ( ₩109.93 Billion KRW).
- Pluristem (TA:PSTI): Ranked #23041 globally with a market cap of $34.78 Million USD ( ILA12.97 Billion ILA).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #8741 | Peptron Inc | KQ:087010 | $973.22 Million | ₩93700.00 |
| #19020 | Bioneer Corporation | KQ:064550 | $100.18 Million | ₩6690.00 |
| #20165 | Macrogen Inc | KQ:038290 | $74.50 Million | ₩10970.00 |
| #23041 | Pluristem | TA:PSTI | $34.78 Million | ILA401.00 |
Market Capitalization of Cell Biotech Co. Ltd (2015–2026)
Market capitalization of Cell Biotech Co. Ltd from 2015 to today. Between 2015 and today, Cell Biotech Co. Ltd's market cap moved from $244.96 Million to $ 77.90 Million, with a yearly change of -10.53%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩77.90 Million | +13.58% |
| 2025 | ₩68.59 Million | -8.13% |
| 2024 | ₩74.66 Million | +27.18% |
| 2023 | ₩58.70 Million | -7.98% |
| 2022 | ₩63.79 Million | -30.24% |
| 2021 | ₩91.44 Million | -17.81% |
| 2020 | ₩111.25 Million | +26.56% |
| 2019 | ₩87.90 Million | -30.23% |
| 2018 | ₩126.00 Million | -28.42% |
| 2017 | ₩176.02 Million | -16.62% |
| 2016 | ₩211.10 Million | -13.82% |
| 2015 | ₩244.96 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Cell Biotech Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $77.90 Million USD |
| MoneyControl | $77.90 Million USD |
| MarketWatch | $77.90 Million USD |
| marketcap.company | $77.90 Million USD |
| Reuters | $77.90 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Cell Biotech Co. Ltd
Cell Biotech Co., Ltd., a biotechnology company, develops and sells lactic acid bacteria in South Korea. It also offers probiotic products under the Nutra DUOLAC, LACTOClear, and LAB2PRO brands. The company also exports its products to approximately 40 countries, including the United States, Europe, Japan, and China. Cell Biotech Co., Ltd. was founded in 1995 and is based in Gimpo-si, South Korea.